0001562180-20-007081.txt : 20201204
0001562180-20-007081.hdr.sgml : 20201204
20201204164853
ACCESSION NUMBER: 0001562180-20-007081
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201202
FILED AS OF DATE: 20201204
DATE AS OF CHANGE: 20201204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith-Farrell Joanne
CENTRAL INDEX KEY: 0001304048
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 201370402
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
STREET 2: C/O BLUEBIRD BIO, INC.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-12-02
false
0001293971
bluebird bio, Inc.
BLUE
0001304048
Smith-Farrell Joanne
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE
MA
02142
false
true
false
false
COO, Oncology
Common Stock
2020-12-02
4
S
false
37.00
46.1895
D
21939.00
D
Common Stock
2020-12-02
4
S
false
1.00
46.50
D
21938.00
D
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
The range in prices for the transaction reported on this line was $45.48 to $46.37. The average weighted price was $46.1895. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Helen C. Fu, Attorney-in-Fact
2020-12-04